Onc.AI Alternatives & Competitors

12 companies similar to Onc.AI — Non-invasive radiomic-based biomarkers for clinical decision support

radiomics.bio

Radiomics, Deep Learning & Federated Learning for AI powered drug development trajectory a...

Liege, Belgium

AI Biotechnology +1

Compare

ArtiQ

Providing AI software to optimize clinical trials and enhance diagnostic processes to imp...

20 Acquired $1.15M

Leuven, Belgium

AI Biotechnology +2

Compare

ImCheck Therapeutics

Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic

57 Grant $193.11M

Marseille, France

Biopharma Biotechnology +3

NextPoint Therapeutics, Inc.

Launching a new world of precision therapeutics through its leading scientific work on th...

38 $122.48M

Biotechnology Health Care +2

Track all Onc.AI competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Massive Bio

AI-driven system connecting cancer patients to clinical trials in real time. Industrializi...

103 Series B $28.10M

Istanbul, Turkey

AI Big Data +5

OncoDNA

Genomic and theranostic company specializing in precision medicine for the treatment of ca...

52 Series C $35.38M

Belgium

Biotechnology Health Care

Ophiomics

Precision Medicine solutions

11 Grant $828.39K

Portugal

Biotechnology Health Care

DxTerity

Bringing the power of precision medicine to autoimmune disease

31 Venture round $3.79M

Rancho Dominguez, United...

Biotechnology Health Care

Congenica

Driving Precision Medicine

24 Series C $74.70M

Cambridge, United Kingdom

Biotechnology Health Care +1

PathAI

Improving patient outcomes with AI-powered pathology.

281 Debt Financing $355.20M

Boston, United States

Biotechnology Health Care

Engine Biosciences

Deciphering Biological Complexity to Unleash Many Impactful Medicines

36 Series A $103.00M

Singapore, Singapore

AI Biotechnology +2

PrecisionLife

AI-driven precision medicine for complex, chronic diseases. Creating better diagnostics &...

33 Grant $2.50M

Oxford, United Kingdom

Biotechnology Health Care

About Onc.AI

Onc.AI, founded in 2020, is making significant strides in the Biotechnology and Health Care industries. This United States-based company provides non-invasive radiomic-based biomarkers designed to support clinical decision-making. True to their slogan, "Non-invasive radiomic-based biomarkers for clinical decision suppo...

Services

AI Model Development for Oncology, Clinical Outcome Prediction, Integration of Diagnostic Imaging and Genomics, Real-World Oncology Data Utilization

Target Customers

Medical Oncologists, Pharmaceutical Companies, Healthcare Institutions, Clinical Researchers

Business keywords

Imaging-AI, Clinical Decision Support, Immunotherapy Optimization, Radiomics, Oncology Diagnostics, Deep Learning, Actionable Insights, Immune Checkpoint Inhibitors, Genomics, Proteomics, Precision Medicine, Healthcare Software, Non-invasive Biomarkers

Business Model

B2B, SaaS

Revenue Model

Subscription, Service Fee, Performance Based

Frequently Asked Questions

Companies similar to Onc.AI include radiomics.bio, ArtiQ, ImCheck Therapeutics, NextPoint Therapeutics, Inc., Massive Bio. They work in Biotechnology and Health Care and share Onc.AI's focus on precision medicine, clinical decision support and genomics.

Bounce Watch lists 12 companies that share Onc.AI's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Onc.AI and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Onc.AI Profile radiomics.bio Alternatives ArtiQ Alternatives ImCheck Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Onc.AI on 28 Jan 2026. The 12 companies listed here were last checked between 14 Sep 2024 and 2 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.